An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2)

Clinical trial NCT01442064 · COMPLETED

Trial details

NCT number: NCT01442064
Sponsor: Genentech, Inc.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Macular Edema Retinal Vein Occlusion

Start date: 2008-07-01
Primary completion: 2010-07-01
Enrollment: 608

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.